• Why Celgene's Acquisition Of Juno Matters For Biotech And Investors

    Forbes | Celgene just acquired immunotherapy biotech Juno Therapeutics in a $9 billion dollar deal. The deal will allow Celgene to compete in a space already occupied by Novartis and Gilead as they vie for hegemony in a new field of oncology.

    Jan 23, 2018

  • Packing A Genome, Step-by-Step

    HHMI | For the first time, scientists can see in minute-time resolution how cells package chromosomes into highly condensed structures prior to cell division.

    Jan 19, 2018

  • CRISPR And Reddit: Doudna Hosts “Ask Me Anything” Session

    Bio-IT World | Jennifer Doudna hosted an “Ask Me Anything” session on Reddit with assistance from her colleagues at Doudna Lab and at the National Human Genome Research Institute. Topics from the session include CRISPR/Cas9 litigation, potential immunity to CRISPR, Designer Babies, and more.

    Jan 19, 2018

  • PacBio Outlook 2018

    Omics! Omics! | Keith Robison gives his take on PacBio's recent presentation at the JP Morgan Healthcare Conference.

    Jan 18, 2018

  • Why Gene Therapy Is No Longer A Pipe Dream

    Pacific Standard | After decades of disappointment, cures to once-incurable diseases seem within reach.

    Jan 18, 2018

  • Celgene In Talks To Buy Juno Therapeutics

    New York Business Journal | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction.

    Jan 17, 2018

  • Has Bio-IT Soured On Cloud?

    Bio-IT World | Bio-IT has swung the gamut of opinions on cloud solutions. First wary, then warming, now, perhaps, pulling back. The inconsistency comes as use cases evolve and costs are closely watched. But there’s no denying that the cloud lets researchers do things they’ve never done before. The trick is finding the right balance.

    Jan 17, 2018

  • Howard Jacob Leaving HudsonAlpha For AbbVie

    Bio-IT World | Less than three years after leaving the Medical College of Wisconsin for the HudsonAlpha Institute in Huntsville, Alabama, Howard Jacob is starting today as the Vice President of the Genomic Research Center at AbbVie.

    Jan 16, 2018